Name: Sofosbuvir 3’,5’-Bis-(S)-phosphate
Brand: Clearsynth
SKU: CS-T-84999
Availability: LimitedAvailability

Sofosbuvir 3’,5’-Bis-(S)-phosphate

Impurity · API Family: Sofosbuvir · CAT No. CS-T-84999 · CAS No. 1337482-17-3

Stock Status: Enquire

Live

Added to RFQ

For Research & Analytical Purposes. Not for Personal use.

Packaging & Handling

Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.

Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.

Storage: Refer MSDS for complete information.

Hazard: Refer MSDS for accurate information.

Sofosbuvir 3’,5’-Bis-(S)-phosphate Product Information

Sofosbuvir 3’,5’-Bis-(S)-phosphate is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Sofosbuvir. The product is supplied by Clearsynth under CAT No. CS-T-84999.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Technical Data

Product Name

Sofosbuvir 3’,5’-Bis-(S)-phosphate

CAS No.

1337482-17-3

CAT No.

CS-T-84999

HSN Code

38229010

Country of Origin

Can be shipped from India, Canada and USA

Molecular Formula

C³⁴H⁴⁵FN⁴O¹³P₂

Molecular Weight

798.69

Description

Regulatory Description

Sofosbuvir 3’,5’-Bis-(S)-phosphate is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir 3’,5’-Bis-(S)-phosphate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Sofosbuvir.

Overview

Sofosbuvir 3',5'-Bis-(S)-phosphate is an impurity of PSI-7977, a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-a-fluoro-ß-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.

Synonyms

Sofosbuvir 3’,5’-Bis-(S)-phosphate

Application Notes

References

CAS
PubChem
Wikipedia

Quick Actions

Send Enquiry Download MSDS

Compliance Note

This product is intended for laboratory research use only. Refer MSDS and product documentation before handling.

Product Applications & Regulatory Search Terms

Useful product, supplier and regulatory search terms for this reference standard.

Buy 1337482-17-3Purchase 1337482-17-3Order 1337482-17-3Enquire 1337482-17-3Price of 1337482-17-31337482-17-3 Supplier1337482-17-3 Manufacturer1337482-17-3 ExporterBuy high quality Sofosbuvir 3’,5’-Bis-(S)-phosphatePurchase Sofosbuvir 3’,5’-Bis-(S)-phosphateSofosbuvir 3’,5’-Bis-(S)-phosphate SuppliersSofosbuvir 3’,5’-Bis-(S)-phosphate ManufacturersSofosbuvir 3’,5’-Bis-(S)-phosphate PriceOrder Sofosbuvir 3’,5’-Bis-(S)-phosphateEnquire Sofosbuvir 3’,5’-Bis-(S)-phosphateSofosbuvir 3’,5’-Bis-(S)-phosphate CostSofosbuvir 3’,5’-Bis-(S)-phosphate SupplierSofosbuvir 3’,5’-Bis-(S)-phosphate DistributorSofosbuvir 3’,5’-Bis-(S)-phosphate for Method ValidationSofosbuvir 3’,5’-Bis-(S)-phosphate for ANDA FilingSofosbuvir 3’,5’-Bis-(S)-phosphate for Forced Degradation StudiesSofosbuvir 3’,5’-Bis-(S)-phosphate Identification StandardsSofosbuvir 3’,5’-Bis-(S)-phosphate for DMF FilingSofosbuvir Reference Standard

Sofosbuvir 3’,5’-Bis-(S)-phosphate

Quality, Documentation & Compliance

Sofosbuvir 3’,5’-Bis-(S)-phosphate

Packaging & Handling

Sofosbuvir 3’,5’-Bis-(S)-phosphate Product Information

Technical Data

Description

Product Applications & Regulatory Search Terms

Tell us what you need

Selected RFQ Items